array(3) { ["company_details"]=> array(13) { ["name"]=> string(27) "BOOTS INTERNATIONAL LIMITED" ["slug"]=> string(36) "d6155-gb-boots-international-limited" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/c48869a8-5470-4069-ad6e-886fee8b8d76" ["description"]=> string(1179) "Boots UK (boots.com), the UK’s largest pharmacy-led health and beauty retailer, is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. With more than 170 years of trusted healthcare heritage and innovation in community pharmacy, the company is meeting customers’ and patients’ needs through its convenient retail locations, digital platforms and health and beauty products. With 2,465* stores in the UK, its purpose is to champion everyone’s right to feel good. Boots UK is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare and offer innovative 'only at Boots'​ exclusive products such as No7, a leading UK skincare brand, Soap and Glory and Liz Earle. Created 170 years ago, the Boots brand is still at the heart of the communities it serves. *As of August 31, 2019 excluding equity method investments" ["address_street"]=> string(11) "Po Box 5300" ["address_place"]=> string(10) "NOTTINGHAM" ["address_region"]=> NULL ["founding_date"]=> NULL ["website_domain"]=> string(10) "boots.jobs" ["website_url"]=> string(22) "https://www.boots.jobs" ["industry_codes"]=> array(1) { [0]=> string(50) "Drugs, Drug Proprietaries, and Druggists' Sundries" } ["employee_count"]=> int(52) ["article_count"]=> int(89) } ["articles"]=> array(2) { [0]=> array(7) { ["title_en"]=> string(138) "Boots UK to consolidate number of stores in close proximity to each other - Latest Pharmacy News | Business | Magazine - Pharmacy Business" ["snippet_en"]=> string(300) "Boots UK has unveiled its plan while announcing the Q3 result on Tuesday (27 June), to close 300 stores in 'close proximity to each other' over the next year. `` Evolving the store estate in this way allows Boots to concentrate its team members where they are needed and focus investment more acutely" ["url"]=> string(99) "https://www.pharmacy.biz/boots-uk-to-consolidate-number-of-stores-in-close-proximity-to-each-other/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/913a7307-8832-4dab-8275-c5e1b41fa253" ["source"]=> string(12) "pharmacy.biz" ["publication_date"]=> string(10) "2023-06-28" ["categories"]=> array(6) { [0]=> string(25) "Business Model Resilience" [1]=> string(10) "Downsizing" [2]=> string(10) "Divestment" [3]=> string(18) "Ecological Impacts" [4]=> string(18) "General Investment" [5]=> string(14) "Product Launch" } } [1]=> array(7) { ["title_en"]=> string(12) "Boots (SWOT)" ["snippet_en"]=> string(232) "Boots’ merger with Walgreens, the largest drugstore operator in the US, provided huge scale and Boots UK has benefited from the group’s technological investment and other synergies. In the UK, Boots is the largest chemist chain." ["url"]=> string(85) "https://www.retail-week.com/retail-navigator/boots/boots-swot/7038196.supplierarticle" ["image_url"]=> NULL ["source"]=> string(15) "retail-week.com" ["publication_date"]=> string(10) "2021-04-13" ["categories"]=> array(4) { [0]=> string(18) "General Investment" [1]=> string(23) "Supply Chain Management" [2]=> string(6) "Merger" [3]=> string(21) "Competitive Behaviour" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(10) "Downsizing" ["count"]=> int(6) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(6) } [2]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(5) } [3]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(5) } [4]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(5) } [5]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(5) } [6]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(4) } [7]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(4) } [8]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(4) } [9]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(4) } [10]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(4) } [11]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(3) } [12]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(3) } [13]=> array(2) { ["name"]=> string(21) "Financial Performance" ["count"]=> int(3) } [14]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(3) } [15]=> array(2) { ["name"]=> string(6) "Merger" ["count"]=> int(2) } [16]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(2) } [17]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(2) } [18]=> array(2) { ["name"]=> string(19) "Government Policies" ["count"]=> int(2) } [19]=> array(2) { ["name"]=> string(21) "Competitive Behaviour" ["count"]=> int(2) } [20]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(2) } [21]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(2) } [22]=> array(2) { ["name"]=> string(23) "Real estate development" ["count"]=> int(2) } [23]=> array(2) { ["name"]=> string(22) "Business Restructuring" ["count"]=> int(2) } [24]=> array(2) { ["name"]=> string(14) "Reorganisation" ["count"]=> int(1) } [25]=> array(2) { ["name"]=> string(16) "Safety Disregard" ["count"]=> int(1) } [26]=> array(2) { ["name"]=> string(12) "Slash Prices" ["count"]=> int(1) } [27]=> array(2) { ["name"]=> string(12) "Staff hiring" ["count"]=> int(1) } [28]=> array(2) { ["name"]=> string(25) "Start-up's & New Business" ["count"]=> int(1) } [29]=> array(2) { ["name"]=> string(6) "Strike" ["count"]=> int(1) } } } d6155-gb-boots-international-limited

BOOTS INTERNATIONAL LIMITED

Location

Founded

Website

https://www.boots.jobs

Articles

89 Articles

Category

Drugs, Drug Proprietaries, and Druggists' Sundries

Description

Boots UK (boots.com), the UK’s largest pharmacy-led health and beauty retailer, is part of the Retail Pharmacy International Division of Walgreens Boots Alliance, Inc. (Nasdaq: WBA), the first global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance (Nasdaq: WBA) is a global leader in retail pharmacy, impacting millions of lives every day through dispensing medicines, and providing accessible, high-quality care. With more than 170 years of trusted healthcare heritage and innovation in community pharmacy, the company is meeting customers’ and patients’ needs through its convenient retail locations, digital platforms and health and beauty products. With 2,465* stores in the UK, its purpose is to champion everyone’s right to feel good. Boots UK is committed to providing exceptional customer and patient care, be the first choice for pharmacy and healthcare and offer innovative 'only at Boots'​ exclusive products such as No7, a leading UK skincare brand, Soap and Glory and Liz Earle. Created 170 years ago, the Boots brand is still at the heart of the communities it serves. *As of August 31, 2019 excluding equity method investments

Articles

Boots UK to consolidate number of stores in close proximity to each other - Latest Pharmacy News | Business | Magazine - Pharmacy Business

2023-06-28 (pharmacy.biz)

Boots UK to consolidate number of stores in close proximity to each other - Latest Pharmacy News | Business | Magazine - Pharmacy Business

Boots UK has unveiled its plan while announcing the Q3 result on Tuesday (27 June), to close 300 stores in 'close proximity to each other' over the next year. `` Evolving the store estate in this way allows Boots to concentrate its team members where they are needed and focus investment more acutely

Read more
Boots (SWOT)

2021-04-13 (retail-week.com)

Boots (SWOT)

Boots’ merger with Walgreens, the largest drugstore operator in the US, provided huge scale and Boots UK has benefited from the group’s technological investment and other synergies. In the UK, Boots is the largest chemist chain.

Read more

Newsletter subscription